ENTRY       D02666                      Drug
NAME        Iloperidone (USAN/INN);
            Fanapt (TN)
PRODUCT     FANAPT (Vanda Pharmaceuticals)
  GENERIC   ILOPERIDONE (Mylan Pharmaceuticals)
            ILOPERIDONE (Taro Pharmaceuticals U.S.A.)
FORMULA     C24H27FN2O4
EXACT_MASS  426.1955
MOL_WEIGHT  426.4806
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03005  Serotonin-dopamine antagonist (SDA)
             DG03200  Antipsychotic agent
              DG03064  Atypical antipsychotic
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: N05AX14
            Product: D02666<US>
EFFICACY    Antipsychotic
COMMENT     Risperidone derivative
TARGET      DRD2 [HSA:1813] [KO:K04145]
            HTR2 [HSA:3356 3357 3358] [KO:K04157]
  PATHWAY   hsa04080(1813+3356+3357+3358)  Neuroactive ligand-receptor interaction
            hsa04726(3356+3357+3358)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AX Other antipsychotics
                 N05AX14 Iloperidone
                  D02666  Iloperidone (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              2nd Generation/Atypical
               Iloperidone
                D02666  Iloperidone (USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                D02666  Iloperidone
              DG03005  Serotonin-dopamine antagonist (SDA)
               D02666  Iloperidone
              DG03200  Antipsychotic agent
               DG03064  Atypical antipsychotic
                D02666  Iloperidone
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D02666  Iloperidone
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D02666  Iloperidone
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D02666  Iloperidone (USAN/INN) &lt;US&gt;
               Serotonin
                HTR2
                 D02666  Iloperidone (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02666
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02666
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02666
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D02666
DBLINKS     CAS: 133454-47-4
            PubChem: 17396835
            ChEBI: 65173
            LigandBox: D02666
            NIKKAJI: J550.684K
ATOM        31
            1   O2x O    20.8600  -29.1900
            2   C8y C    21.2800  -30.5200
            3   C8y C    22.6800  -30.5200
            4   C8y C    23.1000  -29.1900
            5   N5x N    21.9800  -28.3500
            6   C1x C    24.2900  -27.0900
            7   C1y C    24.2900  -28.4900
            8   C1x C    25.4800  -29.1900
            9   C1x C    26.7400  -28.4900
            10  N1y N    26.7400  -27.0900
            11  C1x C    25.4800  -26.3900
            12  C8x C    20.5800  -31.7324
            13  C8y C    21.2800  -32.9449
            14  C8x C    22.6800  -32.9449
            15  C8x C    23.3800  -31.7324
            16  X   F    20.5690  -34.1760
            17  C1b C    27.9466  -26.3800
            18  C1b C    29.1563  -27.0653
            19  C1b C    30.3766  -26.3470
            20  O2a O    31.5858  -27.0313
            21  C8y C    32.7852  -26.3249
            22  C8y C    33.9824  -27.0024
            23  C8x C    35.1888  -26.2920
            24  C8y C    35.1768  -24.8921
            25  C8x C    33.9796  -24.2146
            26  C8x C    32.7732  -24.9249
            27  C5a C    36.3949  -24.1743
            28  C1a C    37.6068  -24.8596
            29  O5a O    36.3821  -22.7501
            30  O2a O    33.9250  -28.4193
            31  C1a C    32.7046  -29.0596
BOND        34
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 2
            5     1   5 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11    6  11 1
            12    7   4 1
            13    2  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    3  15 2
            18   13  16 1
            19   10  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   24  25 1
            28   25  26 2
            29   21  26 1
            30   24  27 1
            31   27  28 1
            32   27  29 2
            33   22  30 1
            34   30  31 1
///
